Deferasirox in pyruvate kinase deficiency
- PMID: 18810437
- DOI: 10.1007/s00277-008-0610-9
Deferasirox in pyruvate kinase deficiency
Comment on
-
Deferasirox in MDS patients with transfusion-caused iron overload--a phase-II study.Ann Hematol. 2009 Apr;88(4):301-10. doi: 10.1007/s00277-008-0588-3. Epub 2008 Aug 29. Ann Hematol. 2009. PMID: 18758781 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
